摘要
Objective: To investigate whether a rapid access approach is useful for the ev aluation of patients with symptoms suggestive of a new cardiac arrhythmia. Desig n: Prospective, descriptive study. Setting: Secondary care based rapid access ar rhythmia clinic in West London, UK. Participants: Patients referred by their gen eral practitioner or the emergency department with symptoms suggestive of a new cardiac arrhythmia. Main outcome measures: Number of patients with a newly diagn osed significant arrhythmia. Number of patients with diagnosed atrial fibrillati on. Number of eligible, moderate, and high risk patients treated with warfarin. Results: Over a 25 month period 984 referrals were assessed. The mean age was 55 years (range 20-90 years) and 56%were women. The median time from referral to assessment was one day. A significant cardiac arrhythmia was newly diagnosed in 40%of patients referred to the RAAC. The most common arrhythmia was atrial fib rillation, with 203 new cases (21%). Of these, 74%of eligible patients over 65 were treated with warfarin. Other arrhythmias diagnosed were supraventricular tachycardias (127(13%)), conduction disorders (43 (4%)), and non-sustained ventricular tachycardia (21 (2%)). Vasovagal syn cope was diagnosed for 53 patients (5%). The most frequent diagnosis was sympto matic ventricular and supraventricular extrasystoles (355 (36%)). Conclusion: A rapid access arrhythmia clinic is an innovative approach to the diagnosis and m anagement of new cardiac arrhythmias in the community. It provides a rapid diagn osis, stratifies risk, and leads to prompt initiation of effective treatment for this population.
Objective: To investigate whether a rapid access approach is useful for the ev aluation of patients with symptoms suggestive of a new cardiac arrhythmia. Desig n: Prospective, descriptive study. Setting: Secondary care based rapid access ar rhythmia clinic in West London, UK. Participants: Patients referred by their gen eral practitioner or the emergency department with symptoms suggestive of a new cardiac arrhythmia. Main outcome measures: Number of patients with a newly diagn osed significant arrhythmia. Number of patients with diagnosed atrial fibrillati on. Number of eligible, moderate, and high risk patients treated with warfarin. Results: Over a 25 month period 984 referrals were assessed. The mean age was 55 years (range 20-90 years) and 56%were women. The median time from referral to assessment was one day. A significant cardiac arrhythmia was newly diagnosed in 40%of patients referred to the RAAC. The most common arrhythmia was atrial fib rillation, with 203 new cases (21%). Of these, 74%of eligible patients over 65 were treated with warfarin. Other arrhythmias diagnosed were supraventricular tachycardias (127(13%)), conduction disorders (43 (4%)), and non-sustained ventricular tachycardia (21 (2%)). Vasovagal syn cope was diagnosed for 53 patients (5%). The most frequent diagnosis was sympto matic ventricular and supraventricular extrasystoles (355 (36%)). Conclusion: A rapid access arrhythmia clinic is an innovative approach to the diagnosis and m anagement of new cardiac arrhythmias in the community. It provides a rapid diagn osis, stratifies risk, and leads to prompt initiation of effective treatment for this population.
